vs
Side-by-side financial comparison of Cheche Group Inc. (CCG) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Cheche Group Inc. is the larger business by last-quarter revenue ($32.8M vs $18.3M, roughly 1.8× ROCKWELL MEDICAL, INC.). Cheche Group Inc. runs the higher net margin — 0.5% vs -3.0%, a 3.5% gap on every dollar of revenue.
Cheche Group Inc. is a leading automotive digital service provider headquartered in China. It offers integrated solutions including auto insurance intermediary services, smart auto after-sales support, and connected vehicle technology products, serving individual car owners, auto dealerships, and insurance partners across domestic and select Southeast Asian markets.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CCG vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.8M | $18.3M |
| Net Profit | $153.6K | $-554.0K |
| Gross Margin | 5.7% | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 0.5% | -3.0% |
| Revenue YoY | — | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | $0.00 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $32.8M | — | ||
| Q4 25 | — | $18.3M | ||
| Q3 25 | — | $15.9M | ||
| Q2 25 | $26.0M | $16.1M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | $18.6M | $24.7M | ||
| Q3 24 | — | $28.3M | ||
| Q2 24 | $36.1M | $25.8M |
| Q1 26 | $153.6K | — | ||
| Q4 25 | — | $-554.0K | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | $-492.4K | $-1.5M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | $-196.7K | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | $-7.6M | $343.0K |
| Q1 26 | 5.7% | — | ||
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | 4.9% | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | 5.2% | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | 4.3% | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | -2.0% | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | -0.3% | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | -4.7% | 2.0% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | — | -3.0% | ||
| Q3 25 | — | -11.0% | ||
| Q2 25 | -1.9% | -9.3% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | -1.1% | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | -21.0% | 1.3% |
| Q1 26 | $0.00 | — | ||
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | $-0.01 | $-0.05 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | $-0.00 | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.0M | $10.7M |
| Total DebtLower is stronger | $193.3K | — |
| Stockholders' EquityBook value | — | $37.0M |
| Total Assets | $203.5M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $20.0M | — | ||
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | $23.1M | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $21.1M | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | $28.2M | $11.9M |
| Q1 26 | $193.3K | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $690.0K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $37.0M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | $47.1M | $30.4M | ||
| Q1 25 | — | $31.5M | ||
| Q4 24 | $49.1M | $32.6M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | $48.6M | $23.5M |
| Q1 26 | $203.5M | — | ||
| Q4 25 | — | $57.1M | ||
| Q3 25 | — | $57.5M | ||
| Q2 25 | $177.3M | $52.6M | ||
| Q1 25 | — | $54.0M | ||
| Q4 24 | $177.7M | $59.2M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | $139.3M | $53.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | $-44.7M | $1.8M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $-15.8M | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | $-1.0K | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $-16.0M | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | $-1.1K | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | -85.9% | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | -0.0% | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | 1.2% | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | 0.0% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCG
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
